Showing results (251-260 of 503) with videos related to
Sort By:
Pageof 51
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MSMarcus W Koch, Carlos Camara-Lemarroy, Eva Strijbis, et al.BMC Neurology|October 10, 2024
Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosisRobert Motl, Whitney Neal, Deborah Backus, et al.JAMA Network Open|April 13, 2026
Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia GravisJoseph Lord, Matthew Walton, Peter Murphy, et al.International Journal of MS Care|January 24, 2014
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis databaseRobert J Fox, Amber R Salter, Tuula Tyry, et al.International Journal of MS Care|June 3, 2016
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple SclerosisJonathan Calkwood, Timothy Vollmer, Robert J Fox, et al.Magnetic Resonance Imaging|July 27, 2018
Scan-rescan repeatability and cross-scanner comparability of DTI metrics in healthy subjects in the SPRINT-MS multicenter trialXiaopeng Zhou, Ken E Sakaie, Josef P Debbins, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implicationsRobert J Fox, Elizabeth Fisher, Jean Tkach, et al.Brain : a Journal of Neurology|August 2, 2008
Neurogenesis in the chronic lesions of multiple sclerosisAnsi Chang, Maria C Smith, Xinghua Yin, et al.Neurology|August 10, 2022
Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple SclerosisJulia O'Mahony, Amber Salter, Beyza Ciftci-Kavaklioglu, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 2023
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosisEva M Strijbis, Eline Coerver, Jop Mostert, et al.Pageof 51